Lentinan

香菇多糖

Report date: 2022/04/26 11:03:28
NME

Base Information

Drug NameLentinan
Drug Alias Name味の素LC-33
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsStomach NeoplasmsHepatitis B, Chronic
Global Approved IndicationsStomach NeoplasmsHepatitis B, Chronic
Approved Indications in ChinaStomach NeoplasmsHepatitis B, Chronic
Original Approved Country/TerritoryJapan
Original Approved Date1985/01/01
Country/TerritoryNorwayMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEa Pharma Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesGlycanova Norge As
Active IndicationsStomach NeoplasmsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeL03AX01
Related LinksWikipediaKEGG